Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2011 | ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment | Lin K.-M.; Chiu Y.-F.; Tsai I.J.; Chen C.-H.; Shen W.W.; Liu S.C.; SHAO-CHUN LU ; Liu C.-Y.; Hsiao M.-C.; Tang H.-S.; Liu S.-I.; Chang L.-H.; CHI-SHIN WU ; Tsou H.-H.; Tsai M.-H.; Chen C.-Y.; Wang S.-M.; Kuo H.-W.; Hsu Y.-T.; Liu Y.-L. | Pharmacogenetics and Genomics | 69 | 77 | |
2006 | Comparison of the electronic structures of Zn1-xCoxO and Zn1-xMgxO nanorods using x-ray absorption and scanning photoelectron microscopies | Chiou J.W.; Tsai H.M.; Pao C.W.; Krishna Kumar K.P.; Ray S.C.; Chien F.Z.; Pong W.F.; Tsai M.-H.; Chen C.-H.; Lin H.-J.; Wu J.J.; Yang M.-H.; Liu S.C.; Chiang H.H.; Chen C.W.; CHUN-WEI CHEN | Applied Physics Letters | 31 | 34 | |
2013 | CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions | Kuo H.-W.; Liu S.C.; Tsou H.-H.; Liu S.-W.; Lin K.-M.; SHAO-CHUN LU ; Hsiao M.-C.; Hsiao C.-F.; Liu C.-Y.; Chen C.-H.; Lu M.-L.; Shen W.W.; Tang H.-S.; Liu S.-I.; Chang L.-H.; Wu H.-Y.; Chang Y.-S.; Yeh T.-K.; Chen A.C.; Liu Y.-L. | Pharmacogenomics | 20 | 15 | |
2010 | CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine | Lin K.-M.; Tsou H.-H.; Tsai I.-J.; Hsiao M.-C.; Hsiao C.-F.; Liu C.-Y.; Shen W.W.; Tang H.-S.; Fang C.-K.; CHI-SHIN WU ; SHAO-CHUN LU ; Kuo H.-W.; Liu S.C.; Chan H.-W.; Hsu Y.-T.; Tian J.-N.; Liu Y.-L. | Pharmacogenomics | 34 | 30 | |
2011 | CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer | Wang S.-C.; Ho I.-K.; Tsou H.-H.; Tian J.-N.; Hsiao C.-F.; Chen C.-H.; Tan H.K.-L.; Lin L.; CHI-SHIN WU ; Su L.-W.; Huang C.-L.; Yang Y.-H.; Liu M.-L.; Lin K.-M.; Chen C.-Y.; Liu S.C.; Wu H.-Y.; Chan H.-W.; Tsai M.-H.; Lin P.-S.; Liu Y.-L. | Journal of Clinical Psychopharmacology | 68 | 59 | |
2013 | Functional genetic polymorphisms in CYP2C19 gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort | Wang S.-C.; Ho I.-K.; Tsou H.-H.; Liu S.-W.; Hsiao C.-F.; Chen C.-H.; Tan H.K.-L.; Lin L.; CHI-SHIN WU ; Su L.-W.; Huang C.-L.; Yang Y.-H.; Liu M.-L.; Lin K.-M.; Liu S.C.; Wu H.-Y.; Kuo H.-W.; Chen A.C.H.; Chang Y.-S.; Liu Y.-L. | OMICS A Journal of Integrative Biology | 37 | 32 | |
2008 | Gene symbol: GLA. Disease: Fabry disease. | Lin W.D.; WUH-LIANG HWU ; Liu S.C.; Tsai F.J. | Human genetics | 1 | 0 | |
2010 | Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response | Tsai M.-H.; Lin K.-M.; Hsiao M.-C.; Shen W.W.; Lu M.-L.; Tang H.-S.; Fang C.-K.; CHI-SHIN WU ; SHAO-CHUN LU ; Liu S.C.; Chen C.-Y.; Liu Y.-L. | Pharmacogenomics | 103 | 91 | |
2007 | Human gene mutations. Gene symbol: GLA. Disease: Fabry disease. | Lin W.D.; WUH-LIANG HWU ; Liu S.C.; Chen C.P.; Tsai F.J. | Human genetics | 3 | 0 | |
2013 | Implementation of fashion ERP systems in China: Case study of a fashion brand, review and future challenges | Choi T.M.; Chow P.S.; Liu S.C.; TSAN MING CHOI | International Journal of Production Economics | 37 | 26 | |
1995 | Molecular diagnosis of Gaucher disease type II. | Tsai F.J.; Chen H.W.; Peng C.T.; Tsai C.H.; WUH-LIANG HWU ; Wang T.R.; Liu S.C. | Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui | 2 | 0 | |
1995 | Sex determination in infants with ambiguous genitalia using the polymerase chain reaction of SRY gene. | Tsai F.J.; Tsai C.H.; WUH-LIANG HWU ; Wang T.R.; Shu S.G.; Liu S.C. | Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui | 0 | 0 | |
2012 | UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients | Tian J.-N.; Ho I.-K.; Tsou H.-H.; Fang C.-P.; Hsiao C.-F.; Chen C.-H.; Tan H.K.-L.; Lin L.; CHI-SHIN WU ; Su L.-W.; Huang C.-L.; Yang Y.-H.; Liu M.-L.; Chen Y.-T.; Liu S.C.; Hsu Y.-T.; Kuo H.-W.; Liu C.T.; Yang Y.-T.; Chen A.C.H.; Shih Y.-H.; Liu Y.-L. | Pharmacogenomics | 29 | 24 |